253
1. Merritt JL II, MacLeod E, Jurecka A, Hainline B. Clinical manifestations and management of fatty acid oxidation disorders. Rev Endocr Metab Disord. 2020;21(3):565–585.
2. Ovcjak A, et al. Diagnostic challenges and outcome of fatty acid oxidation defects: a multicenter study. Orphanet J Rare Dis. 2024;19:151.
3. Peña-Quintana L, Correcher-Medina P. Nutritional Management of Patients with Fatty Acid Oxidation Disorders. Nutrients. 2024;16:2707.
4. Prasun P. Multiple Acyl-CoA Dehydrogenase Deficiency. GeneReviews® [Internet]. University of Washington, Seattle; 1993–2024.
5. Vockley J. Long-chain fatty acid oxidation disorders and current management strategies. Am J Manag Care. 2020;26(Suppl 7):S147–S154. PMID: 32840329. (Açık erişim: PMC9850137)
6. Vockley J. Overview of fatty acid oxidation disorders. In: UpToDate, Connor RF, editor. Waltham (MA): Wolters Kluwer; 2025.